Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula
Background. High-flow nasal cannula (HFNC) is an oxygen delivery method shown to reduce the risk of intubation and mortality in patients with type 1 respiratory failure. The ROX-index score can predict HFNC failure. This study aims to evaluate sequential ROX-index assessments as predictors of HFNC f...
Main Authors: | Dimitris Basoulis, Pantelis Avramopoulos, Maria Aggelara, Georgios Karamanakos, Pantazis-Michail Voutsinas, Amalia Karapanou, Mina Psichogiou, Michalis Samarkos, Foteini Ntziora, Nikolaos V. Sipsas |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2023/7474564 |
Similar Items
-
HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment
by: Dimitris Basoulis, et al.
Published: (2023-02-01) -
ROX index as a predictor of failure of high-flow nasal cannula in infants with bronchiolitis
by: Milena Siciliano Nascimento, et al.
Published: (2024-01-01) -
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
by: Virginie Lemiale, et al.
Published: (2021-01-01) -
The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
by: Lucélia Luna Melo-Diaz, et al.
Published: (2022-11-01) -
Respiratory Rate Oxygenation (ROX) index as predictor of high flow nasal cannula in pediatric patients in pediatric intensive care unit
by: Irene Yuniar, et al.
Published: (2024-05-01)